Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Capping off a year of sustained growth acceleration and stronger than expected FCF generation - surpassing Rule of 40 in 2024 and on track to achieve Rule of 45 in 2025 Culminated a year of accelerate ...

Total revenue increased by 32% to CHF 209m Operating profit tripled to CHF 61mOperating cash flow significantly increased to CHF 74m Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland ...

HighlightsSales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Q4 2024 Earnings Call Transcript February 18, 2025 Arista Networks, Inc. beats earnings expectations. Reported EPS is $0.65, ...

Innovation and operating efficiencies strengthened competitiveness, leading to 6% volume & mix growth and 28% adj. EBITDA ...

Achieves record revenue, GAAP net income1 and adjusted EBITDA2,3 for the fourth quarter and full year 2024Fourth-quarter revenue of $191.5 ...

Q4 2024 Earnings Call Transcript February 14, 2025 Magna International Inc. beats earnings expectations. Reported EPS is ...

Asiatic Laboratories, a pharmaceutical company listed on the stock market, reported a 16% growth in its earnings per share (EPS) for the second quarter, covering the period from October to December.

Boston Pizza Royalties Income Fund Q4 2024 Results Conference Call February 14, 2025 11:30 AM ET. Company Participants. Michael Harbinson - Chief Financial Officer Jordan Holm - P ...